Clinical Trial Update: A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001) [Phase 1]

View source ↗

Summary

Phase 1 trial of MK-4700 alone or with pembrolizumab in advanced or metastatic solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• MK-4700 (MK-4700)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Malignant Neoplasm | Phase 1 | Status: COMPLETED